The growing class of therapies known as GLP-1 receptor stimulators are impacting diabetes treatment, but the delivery method is shifting to a key consideration . Previously, these powerful medications were prescribed solely in capsule form. However, new skin applications are now becoming accessible , causing many people to ask which form is better